Osmind published a paper in Nature Mental Health titled Defining interventional psychiatry: A framework for professional identity and practice evolution, led by experts including William Sauvé, Thomas Insel, Brittany Albright, Martha B. Koo, Rob Berman, Stephen M. Stahl, Husseini Manji, and Roger McIntyre.
Public source
Publisher name
Public post
What exactly is “interventional psychiatry?” The use of this term has become widespread, but it lacks a formal definition. There is also no consensus on how training and…
Company
Osmind
The premier technology platform for breakthrough mental health treatment and research.
- Industry
- Mental Health Care
- Location
- San Francisco, US
- Company size
- 51–200 employees
About Osmind
Osmind is a San Francisco–based public benefit corporation led by scientists, technologists, and psychiatrists to advance new evidence-generating medicine that helps people living with moderate to severe mental health conditions. For more information, please visit osmind.org. We're hiring! Learn more at osmind.org/careers
See moreLatest activity
Latest activity from Osmind
3 signals
Research & Knowledge
Osmind published a new paper in Nature Mental Health titled Defining interventional psychiatry: A framework for professional identity and practice evolution, offering a framework for the field, its definition, and evolution.
Presence & Recognition
Osmind is hosting a 30-minute conversation in the Psychiatry Collective featuring Stephanie Knatz Peck, Ph.D., Co-Founder and CCO, Strata Mental Health, on what site readiness looks like for psilocybin treatment delivery.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
The Menninger Clinic
The Menninger Clinic published new research in Psychiatry Research exploring how reward circuitry may help predict the effects of fMRI-guided accelerated prolonged intermittent theta burst stimulation, or iTBS.
Research & Knowledge
Mentavi Health
Mentavi Health published a study in The Journal of Clinical Psychiatry showing that Mentavi’s asynchronous evaluation agreed with an independent clinical interview in 78% of cases for 345 adults.
Research & Knowledge
Holistic Psychiatry
Holistic Psychiatry notes that CMS's new ACCESS model ties payment for depression and anxiety care to measured improvement on PHQ-9 and GAD-7, not visit counts, launching this July.
Research & Knowledge
Metabolic Psychiatry Labs, Inc.
Metabolic Psychiatry Labs, Inc. published a new feature in Medscape exploring the role of ketogenic metabolic therapy in treating severe mental illness.
Research & Knowledge
Relief Mental Health